Yonina Murciano-Goroff
Clinical Director, Early Drug Development Service · New York Presbyterian Hospital
Credentials: · · · · · · · ·
History
PresentEarly Drug Development Service · New York Presbyterian Hospital
- 2011–2015
Research
The future of cancer immunotherapy: microenvironment-targeting combinations
Cell Research · 2020 · Co-first of 3 authors · 589 citations
EGFR Blockade Reverts Resistance to KRASG12C Inhibition in Colorectal Cancer
Cancer Discovery · 2020 · 430 citations
Diverse alterations associated with resistance to KRAS(G12C) inhibition
Nature · 2021 · Co-first of 28 authors · 390 citations
- AD
20 papers
- ZS
17 papers
- DM
14 papers
12 papers
- BL
12 papers
- KO
12 papers
- MC
10 papers
8 papers
